Predictive Value of the CHA(2)DS(2)-VASc Score on Exercise Capacity in Patients with Cardiovascular Disease

CHA₂DS₂-VASc评分对心血管疾病患者运动能力的预测价值

阅读:1

Abstract

BACKGROUND: Cardiac rehabilitation (CR) improves exercise capacity and is strongly recommended in clinical guidelines. However, no established scoring system exists to predict improvements in exercise capacity following CR. OBJECTIVE: This study aimed to assess whether the CHA(2)DS(2)-VASc score could serve as a predictive scoring system for improvements in exercise capacity after CR. METHODS: Of the 99 patients with cardiovascular disease who participated in the hospital-based CR, those who were ineligible were excluded. The remaining patients were stratified into 2 groups based on the median CHA(2)DS(2)-VASc score. Changes in peak oxygen uptake (peak VO(2)) and clinical parameters from baseline to follow-up were compared between the groups. RESULTS: A total of 46 patients (median age, 74 years; 72% male) were stratified according to the median CHA(2)DS(2)-VASc score of 4. Patients in the high-score group (CHA(2)DS(2)-VASc score ⩾ 4) were older, more likely to be female, and had elevated B-type natriuretic peptide levels compared with those in the low-score group (CHA(2)DS(2)-VASc score <4). The prevalence of comorbidities was similar between the groups. The low-score group showed a significantly greater improvement in peak VO(2) from baseline to follow-up compared with that of the high-score group (2.8 [1.3-4.7] vs 0.4 [-1.0 to 2.4] mL/kg/min, P < 0.01). Spearman's rank correlation analysis showed a significant negative correlation between CHA(2)DS(2)-VASc scores and the change in peak VO(2) between baseline and follow-up (r = -0.37, P = .01). A CHA(2)DS(2)-VASc score <4 was independently associated with an increase in peak VO(2) (β = 0.50, 95% confidence interval 0.23-2.14, P = .01) in the multivariate analysis using multiple linear regression. CONCLUSIONS: The CHA(2)DS(2)-VASc score may be a useful tool for predicting potential improvements in exercise capacity after CR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。